Su, C. 2024. The efficiency, safety, and clinical potential of semorinemab in the treatment of Alzheimer’s disease. Highlights in Science, Engineering and Technology. 99, (Jun. 2024), 232–236. DOI:https://doi.org/10.54097/v4th8q38.